TFPI inhibitors (Novo Nordisk)

N/A

Report date: 2025/03/19 20:00:56

NME

Base Information

Drug NameTFPI inhibitors (Novo Nordisk)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBlood clotting modulators

TargetsUpdating

Therapy Area/IndicationsHemorrhage

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovo Nordisk A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsHemorrhage

ATC CodeN/A